Aviva PLC Bio N Tech Se Transaction History

Aviva PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$205.93 - $447.23 $8.1 Million - $17.6 Million	-39,338 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$113.32 - $241.49 $2.82 Million - $6.01 Million	-24,880 Reduced 38.74%	39,338 $8.85 Million
Q1 2021 May 13, 2021	BUY	$85.73 - $119.5 $4.69 Million - $6.53 Million	54,659 Added 571.81%	64,218 $6.97 Million
Q4 2020 Feb 10, 2021	SELL	$72.71 - $129.54 $636,721 - $1.13 Million	-8,757 Reduced 47.81%	9,559 $852,000
Q3 2020 Nov 12, 2020	SELL	$57.81 - $104.17 $4,856 - $8,750	-84 Reduced 0.46%	18,316 $1.27 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $709,872 - $1.23 Million	18,400 New	18,400 $1.23 Million

360

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.